<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36352367</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>09</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>Central hypersomnia and chronic insomnia: expanding the spectrum of sleep disorders in long COVID syndrome - a prospective cohort study.</ArticleTitle><Pagination><StartPage>417</StartPage><MedlinePgn>417</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">417</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-022-02940-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Long-onset COVID syndrome has been described in patients with COVID-19 infection with persistence of symptoms or development of sequelae beyond 4&#x2009;weeks after the onset of acute symptoms, a medium- and long-term consequence of COVID-19. This syndrome can affect up to 32% of affected individuals, with symptoms of fatigue, dyspnea, chest pain, cognitive disorders, insomnia, and psychiatric disorders. The present study aimed to characterize and evaluate the prevalence of sleep symptoms in patients with long COVID syndrome.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="METHODS">A total of 207 patients with post-COVID symptoms were evaluated through clinical evaluation with a neurologist and specific exams in the subgroup complaining of excessive sleepiness.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 189 patients included in the long COVID sample, 48 (25.3%) had sleep-related symptoms. Insomnia was reported by 42 patients (22.2%), and excessive sleepiness (ES) was reported by 6 patients (3.17%). Four patients with ES were evaluated with polysomnography and test, multiple sleep latencies test, and actigraphic data. Two patients had a diagnosis of central hypersomnia, and one had narcolepsy. A history of steroid use was related to sleep complaints (insomnia and excessive sleepiness), whereas depression was related to excessive sleepiness. We observed a high prevalence of cognitive complaints in these patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Complaints related to sleep, such as insomnia and excessive sleepiness, seem to be part of the clinical post-acute syndrome (long COVID syndrome), composing part of its clinical spectrum, relating to some clinical data.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Moura</LastName><ForeName>Alissa Elen Formiga</ForeName><Initials>AEF</Initials><AffiliationInfo><Affiliation>Hospital Universit&#xe1;rio Walter Cant&#xed;dio, Neurology Service, Universidade Federal do Cear&#xe1;, Fortaleza, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Universidade Federal do Cear&#xe1;, Rua Prof. Costa Mendes, 1608 - 4&#xb0; andar - Rodolfo Te&#xf3;filo, Fortaleza, Cear&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Oliveira</LastName><ForeName>Danilo Nunes</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Hospital Universit&#xe1;rio Walter Cant&#xed;dio, Neurology Service, Universidade Federal do Cear&#xe1;, Fortaleza, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Universidade Federal do Cear&#xe1;, Rua Prof. Costa Mendes, 1608 - 4&#xb0; andar - Rodolfo Te&#xf3;filo, Fortaleza, Cear&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Danielle Mesquista</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Hospital Universit&#xe1;rio Walter Cant&#xed;dio, Neurology Service, Universidade Federal do Cear&#xe1;, Fortaleza, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavares-J&#xfa;nior</LastName><ForeName>Jos&#xe9; Wagner Leonel</ForeName><Initials>JWL</Initials><AffiliationInfo><Affiliation>Hospital Universit&#xe1;rio Walter Cant&#xed;dio, Neurology Service, Universidade Federal do Cear&#xe1;, Fortaleza, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Universidade Federal do Cear&#xe1;, Rua Prof. Costa Mendes, 1608 - 4&#xb0; andar - Rodolfo Te&#xf3;filo, Fortaleza, Cear&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xf3;brega</LastName><ForeName>Paulo Ribeiro</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Hospital Universit&#xe1;rio Walter Cant&#xed;dio, Neurology Service, Universidade Federal do Cear&#xe1;, Fortaleza, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Universidade Federal do Cear&#xe1;, Rua Prof. Costa Mendes, 1608 - 4&#xb0; andar - Rodolfo Te&#xf3;filo, Fortaleza, Cear&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braga-Neto</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Universit&#xe1;rio Walter Cant&#xed;dio, Neurology Service, Universidade Federal do Cear&#xe1;, Fortaleza, Brazil. pbraganeto@ufc.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Universidade Federal do Cear&#xe1;, Rua Prof. Costa Mendes, 1608 - 4&#xb0; andar - Rodolfo Te&#xf3;filo, Fortaleza, Cear&#xe1;, Brazil. pbraganeto@ufc.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Health Sciences, Universidade Estadual do Cear&#xe1;, Fortaleza, Brazil. pbraganeto@ufc.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobreira-Neto</LastName><ForeName>Manoel Alves</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Hospital Universit&#xe1;rio Walter Cant&#xed;dio, Neurology Service, Universidade Federal do Cear&#xe1;, Fortaleza, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Universidade Federal do Cear&#xe1;, Rua Prof. Costa Mendes, 1608 - 4&#xb0; andar - Rodolfo Te&#xf3;filo, Fortaleza, Cear&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007319" MajorTopicYN="Y">Sleep Initiation and Maintenance Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077260" MajorTopicYN="N">Sleepiness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006970" MajorTopicYN="Y">Disorders of Excessive Somnolence</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012893" MajorTopicYN="Y">Sleep Wake Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hypersomnia</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Narcolepsy</Keyword><Keyword MajorTopicYN="N">Sleep</Keyword></KeywordList><CoiStatement>I declare that the all authors have no competing interests as defined by BMC, or other interests that might be perceived to influence the results and/or discussion reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36352367</ArticleId><ArticleId IdType="pmc">PMC9643986</ArticleId><ArticleId IdType="doi">10.1186/s12883-022-02940-7</ArticleId><ArticleId IdType="pii">10.1186/s12883-022-02940-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi: 10.1136/bmj.m1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, et al. Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med. 2020;202:812&#x2013;821. doi: 10.1164/rccm.202005-1583OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-1583OC</ArticleId><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE. https://www.nice.org.uk/guidance/ng188. Accessed 27 Sep 2022.</Citation></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, Berlit P, B&#xf6;ing S, Brinkmann F, et al. S1 guideline post-COVID/long-COVID. Pneumol Stuttg Ger. 2021;75:869&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15:e0243882. doi: 10.1371/journal.pone.0243882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AM, Wong JGWS, McAlonan GM, Cheung V, Cheung C, Sham PC, et al. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can J Psychiatry Rev Can Psychiatr. 2007;52:233&#x2013;240. doi: 10.1177/070674370705200405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/070674370705200405</ArticleId><ArticleId IdType="pubmed">17500304</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahrami H, BaHammam AS, Bragazzi NL, Saif Z, Faris M, Vitiello MV. Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2021;17:299&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7853219</ArticleId><ArticleId IdType="pubmed">33108269</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Inf Secur. 2021;82:378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings G, Monaghan A, Xue F, Mockler D, Romero-Ortu&#xf1;o R. A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: ongoing symptomatic phase vs. post-COVID-19 syndrome. J Clin Med. 2021;10:5913. doi: 10.3390/jcm10245913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245913</ArticleId><ArticleId IdType="pmc">PMC8708187</ArticleId><ArticleId IdType="pubmed">34945213</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardo MDM, Foppiani A, Peretti GM, Mangiavini L, Battezzati A, Bertoli S, et al. Long-term coronavirus disease 2019 complications in inpatients and outpatients: a one-year follow-up cohort study. Open forum. Infect Dis. 2021;8:ofab384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8344801</ArticleId><ArticleId IdType="pubmed">34386546</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin CM, Jarrin DC. Epidemiology of insomnia: prevalence, course, risk factors, and public health burden. Sleep Med Clin. 2022;17(2):173&#x2013;191. doi: 10.1016/j.jsmc.2022.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsmc.2022.03.003</ArticleId><ArticleId IdType="pubmed">35659072</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes-Oliveira MH, Gorenstein C, Lotufo Neto F, Andrade LH, Wang YP. Validation of the Brazilian Portuguese version of the Beck depression inventory-II in a community sample. Braz J Psychiatry. 2012;34:389&#x2013;394. doi: 10.1016/j.rbp.2012.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbp.2012.03.005</ArticleId><ArticleId IdType="pubmed">23429809</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida OP, Almeida SA. Reliability of the Brazilian version of the geriatric depression scale (GDS) short form. Arq Neuropsiquiatr. 1999;57:421&#x2013;426. doi: 10.1590/S0004-282X1999000300013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X1999000300013</ArticleId><ArticleId IdType="pubmed">10450349</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitrini R, Caramelli P, Bottino CM de C, Damasceno BP, Brucki SMD, Anghinah R. Diagn&#xf3;stico de doen&#xe7;a de Alzheimer no Brasil: avalia&#xe7;&#xe3;o cognitiva e funcional. Recomenda&#xe7;&#xf5;es do Departamento Cient&#xed;fico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia. Arq Neuropsiquiatr. 2005;63:720&#x2013;727. doi: 10.1590/S0004-282X2005000400034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X2005000400034</ArticleId><ArticleId IdType="pubmed">16172733</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xe9;sar KG, Yassuda MS, Porto FHG, Brucki SMD, Nitrini R. Addenbrooke&#x2019;s cognitive examination-revised: normative and accuracy data for seniors with heterogeneous educational level in Brazil. Int Psychogeriatr. 2017;29:1345&#x2013;1353. doi: 10.1017/S1041610217000734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610217000734</ArticleId><ArticleId IdType="pubmed">28511735</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera E, Caramelli P, Silveira ASB, Nitrini R. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord. 2002;16:103&#x2013;108. doi: 10.1097/00002093-200204000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002093-200204000-00007</ArticleId><ArticleId IdType="pubmed">12040305</ArticleId></ArticleIdList></Reference><Reference><Citation>Brucki SMD, Nitrini R, Caramelli P, Bertolucci PHF, Okamoto IH. Sugest&#xf5;es para o uso do mini-exame do estado mental no Brasil. Arq Neuropsiquiatr. 2003;61:777&#x2013;781. doi: 10.1590/S0004-282X2003000500014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X2003000500014</ArticleId><ArticleId IdType="pubmed">14595482</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry RB, Brooks R, Gamaldo C, Harding SM, Lloyd RM, Quan SF, et al. AASM scoring manual updates for 2017 (version 2.4). J Clin Sleep med JCSM off Publ am Acad. Sleep Med. 2017;13:665&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5406946</ArticleId><ArticleId IdType="pubmed">28416048</ArticleId></ArticleIdList></Reference><Reference><Citation>Iber C, American Academy of Sleep Medicine . The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westchester, IL: American Academy of Sleep Medicine; 2007.</Citation></Reference><Reference><Citation>Littner MR, Kushida C, Wise M, Davila DG, Morgenthaler T, Lee-Chiong T, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep. 2005;28:113&#x2013;121. doi: 10.1093/sleep/28.1.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/28.1.113</ArticleId><ArticleId IdType="pubmed">15700727</ArticleId></ArticleIdList></Reference><Reference><Citation>Muccioli L, Pensato U, Cani I, Guarino M, Cortelli P, Bisulli F. COVID-19-associated encephalopathy and cytokine-mediated Neuroinflammation. Ann Neurol. 2020;88:860&#x2013;861. doi: 10.1002/ana.25855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25855</ArticleId><ArticleId IdType="pubmed">32715524</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M, Le Coupanec A, Stodola JK, Meessen-Pinard M, Talbot PJ. Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res. 2014;194:145&#x2013;158. doi: 10.1016/j.virusres.2014.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.09.011</ArticleId><ArticleId IdType="pmc">PMC7114389</ArticleId><ArticleId IdType="pubmed">25281913</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordvig AS, Fong KT, Willey JZ, Thakur KT, Boehme AK, Vargas WS, et al. Potential neurologic manifestations of COVID-19. Neurol Clin Pract. 2021;11:e135&#x2013;e146. doi: 10.1212/CPJ.0000000000000897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000000897</ArticleId><ArticleId IdType="pmc">PMC8032406</ArticleId><ArticleId IdType="pubmed">33842082</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol (Berl) 2020;140:1&#x2013;6. doi: 10.1007/s00401-020-02166-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02166-2</ArticleId><ArticleId IdType="pmc">PMC7245994</ArticleId><ArticleId IdType="pubmed">32449057</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, et al. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol. 2019;10:2247. doi: 10.3389/fimmu.2019.02247.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02247</ArticleId><ArticleId IdType="pmc">PMC6773825</ArticleId><ArticleId IdType="pubmed">31608061</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med Hypotheses. 2021;146:110469. doi: 10.1016/j.mehy.2020.110469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110469</ArticleId><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12:573&#x2013;580. doi: 10.1021/acschemneuro.0c00793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020;12:69. doi: 10.1186/s13195-020-00640-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00640-3</ArticleId><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther. 2020;12:170. doi: 10.1186/s13195-020-00744-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00744-w</ArticleId><ArticleId IdType="pmc">PMC7772800</ArticleId><ArticleId IdType="pubmed">33380345</ArticleId></ArticleIdList></Reference><Reference><Citation>Plante DT, Finn LA, Hagen EW, Mignot E, Peppard PE. Longitudinal associations of hypersomnolence and depression in the Wisconsin Sleep cohort study. J Affect Disord. 2017;207:197&#x2013;202. doi: 10.1016/j.jad.2016.08.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2016.08.039</ArticleId><ArticleId IdType="pmc">PMC5107142</ArticleId><ArticleId IdType="pubmed">27723544</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasrullah A, Javed A, Ashraf O, Malik K. Possible role of COVID-19 in the relapse of Klein-Levin syndrome. Respir Med Case Rep. 2021;33:101445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164508</ArticleId><ArticleId IdType="pubmed">34094848</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecendreux M, Berthier J, Corny J, Bourdon O, Dossier C, Delclaux C. Intravenous immunoglobulin therapy in pediatric narcolepsy: a nonrandomized, open-label, controlled, longitudinal observational study. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2017;13:441&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5337592</ArticleId><ArticleId IdType="pubmed">28095967</ArticleId></ArticleIdList></Reference><Reference><Citation>Mignot E, Black S. Narcolepsy risk and COVID-19. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2020;16:1831&#x2013;1833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7954017</ArticleId><ArticleId IdType="pubmed">32621581</ArticleId></ArticleIdList></Reference><Reference><Citation>Latorre D, Kallweit U, Armentani E, Foglierini M, Mele F, Cassotta A, et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature. 2018;562:63&#x2013;68. doi: 10.1038/s41586-018-0540-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0540-1</ArticleId><ArticleId IdType="pubmed">30232458</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>